The urokinase type of plasminogen activator in cancer of digestive tracts - PubMed (original) (raw)
The urokinase type of plasminogen activator in cancer of digestive tracts
N Nishino et al. Thromb Res. 1988.
Abstract
The amounts of urokinase (UK) antigen and tissue plasminogen activator (t-PA) antigen were determined in plasma, urine and tissues of patients with cancer of digestive tracts. Urinary levels of UK, but not those of t-PA increased in patients with cancer, and generally decreased after the removal of cancer by operation. Urinary UK levels kept increasing in patients with recurrence of cancer or with metastasis into liver or peritoneum. Plasma levels of t-PA, but not those of UK decreased in patients with cancer. When the amounts of UK were compared in cancer tissues and their adjacent normal mucosal layer, cancer tissues always had higher levels of UK, but t-PA levels were same between tumor tissues and normal mucosa. The results suggest that the type of plasminogen activator was UK-type in cancer of digestive tracts.
Similar articles
- Plasminogen activators in endoscopic biopsies as indicators of gastrointestinal cancer: comparison with resection specimens.
de Bruin PA, Verspaget HW, Griffioen G, Verheijen JH, Dooijewaard G, Lamers CB. de Bruin PA, et al. Br J Cancer. 1989 Sep;60(3):397-400. doi: 10.1038/bjc.1989.293. Br J Cancer. 1989. PMID: 2506920 Free PMC article. - Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder.
Hasui Y, Suzumiya J, Marutsuka K, Sumiyoshi A, Hashida S, Ishikawa E. Hasui Y, et al. Cancer Res. 1989 Feb 15;49(4):1067-70. Cancer Res. 1989. PMID: 2492205 - Plasminogen activators and cancer.
Duffy MJ. Duffy MJ. Blood Coagul Fibrinolysis. 1990 Dec;1(6):681-7. Blood Coagul Fibrinolysis. 1990. PMID: 2133247 Review. - [Tissue plasminogen activator (t-PA) and urokinase plasminogen activator (u-PA)].
Kondo S. Kondo S. Nihon Rinsho. 2004 Dec;62 Suppl 12:700-2. Nihon Rinsho. 2004. PMID: 15658428 Review. Japanese. No abstract available.
Cited by
- Activation of urokinase plasminogen activator and its receptor axis is essential for macrophage infiltration in a prostate cancer mouse model.
Zhang J, Sud S, Mizutani K, Gyetko MR, Pienta KJ. Zhang J, et al. Neoplasia. 2011 Jan;13(1):23-30. doi: 10.1593/neo.10728. Neoplasia. 2011. PMID: 21245937 Free PMC article. - Expression of urokinase-type plasminogen activator and its receptor in gastric fibroblasts and effects of nonsteroidal antiinflammatory drugs and prostaglandin.
Iwamoto J, Takahashi K, Mizokami Y, Otsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokoube K, Matsuoka T. Iwamoto J, et al. Dig Dis Sci. 2003 Dec;48(12):2247-56. doi: 10.1023/b:ddas.0000007859.10680.b1. Dig Dis Sci. 2003. PMID: 14714609 - Expression and localization of urokinase-type plasminogen activator in human spinal column tumors.
Gokaslan ZL, Chintala SK, York JE, Boyapati V, Jasti S, Sawaya R, Fuller G, Wildrick DM, Nicolson GL, Rao JS. Gokaslan ZL, et al. Clin Exp Metastasis. 1998 Nov;16(8):713-9. doi: 10.1023/a:1006528711499. Clin Exp Metastasis. 1998. PMID: 10211984 - The concentration of u-PA and PAI-1 antigen in tissue extracts of nasopharyngeal carcinoma.
Sunagawa M, Huang GW, Nakamura M, Kosugi T. Sunagawa M, et al. Eur Arch Otorhinolaryngol. 1997;254(6):277-80. doi: 10.1007/BF02905987. Eur Arch Otorhinolaryngol. 1997. PMID: 9248735 - Urokinase-type plasminogen activator receptor in gastric cancer: tissue expression and prognostic role.
Plebani M, Herszènyi L, Carraro P, De Paoli M, Roveroni G, Cardin R, Tulassay Z, Naccarato R, Farinati F. Plebani M, et al. Clin Exp Metastasis. 1997 Jul;15(4):418-25. doi: 10.1023/a:1018454305889. Clin Exp Metastasis. 1997. PMID: 9219730 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Medical